Approved Drugs for Dermatology/Plastic Surgery
Altabax (retapamulin); Glaxo;
For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes, Approved April 2007
Extina (ketoconazole); Stiefel;
For the treatment of seborrheic dermatitis, Approved June 2007
Xyzal (levocetirizine dihydrochloride); UCB Inc.;
For the treatment of seasonal and perennial allergic rhinitis and urticaria, Approved May 2007
Desonate (desonide); Dow Pharm;
For the treatment of atopic dermatitis, Approved October 2006
Verdeso (desonide); Connetics;
For the treatment of atopic dermatitis, Approved September 2006
Amevive (alefacept); Biogen;
For moderate to severe chronic plaque psoriasis., Approved January 2003
Finacea (azelaic acid) Gel, 15%; Berlex Laboratories;
Gel formulation for the treatment of rosacea., January 2003
Botox Cosmetic (botulinum toxin type A); Allergan;
For the temporary improvement in the appearance of glabellar lines (brow furrow), Approved April 2002
Elidel; Novartis;
Topical cream for the treatment of atopic dermatitis, Approved December 2001
Estrostep (ethinyl estradiol and norethindrone acetate); Pfizer;
For the treatment of moderate acne vulgaris, Approved July 2001
Finevin; Berlex Laboratories;
Topical cream for the treatment of mild to moderate inflammatory acne vulgaris, Approved May 2001
Invanz; Merck;
Once-daily injectable treatment for bacterial infections, Approved November 2001
Lamisil Solution, 1%; Novartis;
Topical treatment for tinea (pityriasis) versicolor, althete's foot, jock itch, and ringworm, Approved March 2001
Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel); Dermik Laboratories;
For the topical treatment of acne vulgaris, Approved November 2000
Cefazolin and Dextrose USP; B Braun Medical;
Respiratory tract infections, Approved July 2000
Chloraprep (chlorhexidine gluconate); MEDI FLEX HOSP PRODUCTS;
For use as a patient preoperative skin preparation, Approved July 2000
Clindamycin phosphate topical gel; Target Research Associates;
For once a day treatment of acne vulgaris, Approved November 2000
Lamisil (terbinafine hydrochloride) Solution, 1%; Novartis;
For the treatment of athlete's foot, jock itch and ringworm, Approved March 2000
Protopic (tacrolimus) ointment; Fujisawa Healthcare;
For short-term and intermittent long-term treatment of moderate to severe atopic dermatitis, Approved December 2000
Skin Exposure Reduction Paste Against Chemical Warfare Agents (SERPACWA); U.S. Army Medical Research, Material Command;
To reduce absorption of chemical warfare agents through the skin, Approved February 2000
Lamisil/terbinafine Dermgel, 1%; Novartis;
Treatment for tinea pedis (athlete's foot), Approved March 1999
Luxiq (betamethasone valerate) Foam; Connetics Corporation;
Treatment for dermatoses of scalp, Approved June 1999
Avita Gel; Penederm;
Treatment for acne, Approved February 1998
Dynabac; Sanofi Pharmaceuticals;
Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections), Approved March 1998
Lustra; Medicis Pharmaceutical;
Treatment for ultraviolet-induced skin discolorations, Approved January 1998
MetroLotion; Galderma Laboratories;
Treatment of inflammatory papules and pustules of rosacea, Approved November 1998
Noritate; Dermik Laboratories;
Treatment for rosacea, Approved January 1998
Salagen Tablets; MGI Pharma;
Treatment for Sjogren's Syndrome, Approved February 1998
Sulfamylon; Mylan Laboratories;
Treatment used to control bacterial infections on excised burn wounds, Approved June 1998
Thalomid; Celgene;
Treatment for moderate to severe erythema nodosum leprosum (ENL), Approved July 1998
Avita; Penederm;
Treatment for acne, Approved January 1997
Bactroban Cream; SmithKline Beecham;
Treatment for secondarily infected traumatic skin lesions, Approved December 1997
Clindamycin Phosphate Topical Solution USP 1%; Morton Grove Pharmaceuticals;
Generic equivalent of CLEOCIN Topical Solution 1%, Approved July 1997
Condylox Gel 0.5% (pokofilox); Oclassen Pharmaceuticals;
Treatment for external genital and perianal warts, Approved March 1997
Dermagraft-TC; Advanced Tissue Sciences;
Treatment for partial-thickness and severe burns, Approved October 1997
Klaron (sodium sulfacet amide lotion ) Lotion, 10%; Dermik Laboratories;
Treatment for adult acne, Approved February 1997
Mentax; Penederm;
Treatment for athlete's foot, Approved December 1997
Mentax; Penederm;
Treatment for tinea corporis (ringworm) and tinea cruris (groin fungus), Approved January 1997
Minoxidil Topical Solution 2% for Women; Alpharma;
Generic equivalent of Rogaine, Approved April 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol); Ortho Pharmaceutical;
Treatment for acne in women seeking contraception, Approved January 1997
Propecia; Merck;
Treatment for male baldness, Approved December 1997
REGRANEX (becaplermin) Gel; R.W. Johnson;
Treatment for diabetic foot ulcers, Approved December 1997
Retin-A Micro (tretinoin gel) microsphere, 0.1%; Advanced Polymer Systems;
Treatment for acne, Approved February 1997
Tazorac topical gel; Allergan;
Treatment for Psoriasis, Acne Vulgaris, Approved June 1997
Differin (adapalene gel) Gel, 0.1%; Galderma Laboratories;
Treatment for acne, Approved June 1996
Iamin; ProCyte;
Gel wound dressing, Approved February 1996
Iontocaine; Iomed;
Needle-free anesthetic, Approved May 1996
IvyBlock; EnviroDerm Pharmaceuticals;
Treatment for poison ivy, poison oak, and poison sumac, Approved September 1996
Mentax (1% butenafine HCI cream); Penederm;
Treatment for athlete's foot, Approved April 1996
Renova (tretinoin emollient cream); Johnson & Johnson;
Treatment for facial wrinkles, brown spots, and surface roughness associated with chronic sun exposure, Approved December 1995
